Guided Therapeutics approves 1-for-20 reverse stock split; FINRA effective date pending

GUIDED THERAPEUTICS INC

Board approved 1-for-20 reverse split on Dec 30, 2021; Certificate of Amendment filed with Delaware.
Each 20 shares reclassified into 1 share; no fractional shares issued, whole share granted instead.
Options, warrants, and convertible securities adjusted proportionally to reflect the split.
Stockholder approval obtained in July 2021; FINRA has not yet declared effective date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.